Evotec SE
Evotec SE (EVO) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · EVO · as of Sep 30, 2025
Ownership Breakdown
37
Institutional Holders
$35.86M
Total Inst. Value
▼ $4.68M vs Q2
355.19M
Shares Outstanding
freeFloat 94.84%
9.89M
13F Shares Held
▲ 231,224 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
EVO largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
MUBADALA INVESTMENT CO PJSC pharmaceutical preparations | 4.60M | 1.29% | 1.29% | $16.69B | Nov 14, 2025 | — held |
WELLINGTON MANAGEMENT GROUP LLP pharmaceutical preparations | 1.43M | 40.26% | 40.26% | $5.19B | Nov 14, 2025 | ▲ 224.3K |
BLACKROCK, INC. pharmaceutical preparations | 1.30M | 36.60% | 36.60% | $4.72B | Nov 12, 2025 | ▼ 40.3K |
DCF ADVISERS, LLC pharmaceutical preparations | 1.20M | 33.76% | 33.76% | $4.35B | Nov 12, 2025 | ▲ 84.5K |
MORGAN STANLEY pharmaceutical preparations | 314.9K | 8.87% | 8.87% | $1.14B | May 27, 2026 | ▼ 70.3K |
WCM INVESTMENT MANAGEMENT, LLC pharmaceutical preparations | 300.3K | 8.45% | 8.45% | $1.06B | Nov 4, 2025 | ▲ 2.4K |
PITCAIRN CO pharmaceutical preparations | 161.8K | 4.55% | 4.55% | $587.22M | Nov 12, 2025 | ▼ 99.4K |
ABC ARBITRAGE SA pharmaceutical preparations | 132.1K | 3.72% | 3.72% | $479.37M | Nov 6, 2025 | ▲ 93.1K |
CITADEL ADVISORS LLC pharmaceutical preparations | 96.0K | 2.70% | 2.70% | $348.64M | Nov 14, 2025 | ▲ 62.5K |
ENVESTNET ASSET MANAGEMENT INC pharmaceutical preparations | 75.7K | 2.13% | 2.13% | $274.83M | Nov 5, 2025 | ▼ 16.0K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
13
Increased
+530.0K shares6
New Positions
first time holders8
Decreased
−231.3K shares8
Sold Out
fully exitedNet shares change (top 50)
+298.8K
+530.0K / −231.3K
Net new holders
+3
6 new / 8 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
EVO insider trading · insider activity
Source: SEC Form 4
Insiders have been net buyers of shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Anderson Mark Monroe director | Oct 22, 2018 | Award | 100,000 | $2.50 | $250.0K | 100.0K | Form 4 ↗ |
Smith Scott Clifford director | Aug 13, 2018 | Award | 100,000 | $2.50 | $250.0K | 100.0K | Form 4 ↗ |
LAFFER ARTHUR B director | Aug 13, 2018 | Award | 100,000 | $2.50 | $250.0K | 100.0K | Form 4 ↗ |
Zientek Michael Chief Financial Officer | Aug 13, 2018 | Award | 200,000 | $2.50 | $500.0K | 200.0K | Form 4 ↗ |
BANK OF AMERICA CORP /DE/ 10 percent owner | Mar 26, 2018 | J-Other | 134 | — | — | 0 | Form 4 ↗ |
UBS Group AG Former 10% Owner | Feb 26, 2016 | J-Other | 531 | — | — | 0 | Form 4 ↗ |
BANK OF AMERICA CORP /DE/ 10 percent owner | Oct 18, 2011 | Purchase | 92 | $12.83 | $1.2K | 392 | Form 4 ↗ |
BANK OF AMERICA CORP /DE/ 10 percent owner | Oct 18, 2011 | Sale | 92 | $12.72 | $1.2K | 300 | Form 4 ↗ |
BANK OF AMERICA CORP /DE/ 10 percent owner | Oct 18, 2011 | Purchase | 200 | $12.82 | $2.6K | 300 | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Evotec SE (EVO) is primarily owned by institutional investors, who hold approximately 2.8% of total shares outstanding. Company insiders own approximately 5.16%, while retail and public investors account for the remaining 92.06%.
The largest institutional shareholder of Evotec SE is MUBADALA INVESTMENT CO PJSC, holding approximately 4.60 million shares — equal to 1.29% of outstanding shares — as of September 30, 2025.
A total of 37 institutional investors currently hold EVO stock, with a combined institutional value of approximately $35,859,594 as of the most recent 13F filing period.
Frequently asked questions
EVO ownershipEvotec SE (EVO) is primarily owned by institutional investors, who hold approximately 2.8% of shares. The largest shareholder is MUBADALA INVESTMENT CO PJSC with a 1.29% stake. Company insiders hold 5.16%. Data sourced from SEC Form 13F as of September 30, 2025.